The sentiment of the investors rose to 1.42 in the first quarter of 2019. It has increased 0.32 from the previous 1.1 in the last quarter of 2018. The reason behind the improvement is the selling of AERI shares by the investors and the reduction of holding of 41 shares. Positions were opened by 28 funds where stakes were raised by 53 investors. As compared with the last quarter of 2018, there were 4.67 percent fewer shares. 0.01 percent was reported by the State Of Wisconsin Invest Board in Aerie Pharmaceuticals Inc.
Consonance Cap Management LP has a holding of 1.70M. 95 thousand shares were accumulated by Altrinsic Lc. An investment of 8,470 shares was made by Marshall Wace Llp. 524,091 shares were invested by the Highland Capital LP which is equivalent to 1.55 percent of the stock. Zurcher Kantonalbank, which is Swiss-based firm made an investment of 0 percent in Aerie Pharmaceuticals, Inc. An investment of 0 percent was made by Ubs Asset Americas which was equivalent to 31,144 shares.
2,100 shares were reported by Qs Limited Liability Company. Rhumbline Advisers made an investment of 0% which was equivalent to 47,111 shares. Granite Point Mgmt LP invested 0 percent in Aerie Pharmaceuticals, Inc. which was equal to 18,600 shares. In addition to this, Manchester Capital Mngmt Ltd Liability Corporation also invested 0 percent in Aerie Pharmaceuticals, Inc. which was equivalent to 150 shares. 8,642 shares were reported by JPMorgan Chase. Morgan Stanley purchased 508,912 shares which were equivalent to 0.01 percent of the stock. Frontier Cap Com Lc has now the possession of 325,572 shares. Ameritas Prtn Inc also made an investment of 0.01% in Aerie Pharmaceuticals, Inc.
The stake of Provident Investment Management Inc. was also raised by 47.91 percent according to its latest regulatory filing with the SEC of the first quarter of 2019.